Lapteva N - Search Results

1

Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.

Lapteva N, Aldrich M, Weksberg D, Rollins L, Goltsova T, Chen SY, Huang XF. Lapteva N, et al. J Immunother. 2009 Feb-Mar;32(2):145-56. doi: 10.1097/CJI.0b013e318193d31e. J Immunother. 2009. PMID: 19238013 Free PMC article.

2

CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.

Lapteva N, Yang AG, Sanders DE, Strube RW, Chen SY. Lapteva N, et al. Cancer Gene Ther. 2005 Jan;12(1):84-9. doi: 10.1038/sj.cgt.7700770. Cancer Gene Ther. 2005. PMID: 15472715

3

Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation.

Lapteva N, Seethammagari MR, Hanks BA, Jiang J, Levitt JM, Slawin KM, Spencer DM. Lapteva N, et al. Cancer Res. 2007 Nov 1;67(21):10528-37. doi: 10.1158/0008-5472.CAN-07-0833. Cancer Res. 2007. PMID: 17974997

4

SOCS1 downregulation in dendritic cells promotes memory T-cell responses.

Aldrich M, Sanders D, Lapteva N, Huang XF, Chen SY. Aldrich M, et al. Among authors: lapteva n. Vaccine. 2008 Feb 20;26(8):1128-35. doi: 10.1016/j.vaccine.2007.11.020. Epub 2007 Dec 7. Vaccine. 2008. PMID: 18222020 Free PMC article.

5

Attraction and activation of dendritic cells at the site of tumor elicits potent antitumor immunity.

Lapteva N, Aldrich M, Rollins L, Ren W, Goltsova T, Chen SY, Huang XF. Lapteva N, et al. Mol Ther. 2009 Sep;17(9):1626-36. doi: 10.1038/mt.2009.111. Epub 2009 Jun 16. Mol Ther. 2009. PMID: 19532135 Free PMC article.

6

CCL5 as an adjuvant for cancer immunotherapy.

Lapteva N, Huang XF. Lapteva N, et al. Expert Opin Biol Ther. 2010 May;10(5):725-33. doi: 10.1517/14712591003657128. Expert Opin Biol Ther. 2010. PMID: 20233026 Review.

7

Enhanced migration of human dendritic cells expressing inducible CD40.

Lapteva N. Lapteva N. Methods Mol Biol. 2010;651:79-87. doi: 10.1007/978-1-60761-786-0_5. Methods Mol Biol. 2010. PMID: 20686961

8

The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function.

Ramachandran IR, Song W, Lapteva N, Seethammagari M, Slawin KM, Spencer DM, Levitt JM. Ramachandran IR, et al. Among authors: lapteva n. J Immunol. 2011 Apr 1;186(7):3934-45. doi: 10.4049/jimmunol.1001675. Epub 2011 Feb 25. J Immunol. 2011. PMID: 21357539

9

A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy.

Narayanan P, Lapteva N, Seethammagari M, Levitt JM, Slawin KM, Spencer DM. Narayanan P, et al. Among authors: lapteva n. J Clin Invest. 2011 Apr;121(4):1524-34. doi: 10.1172/JCI44327. Epub 2011 Mar 7. J Clin Invest. 2011. PMID: 21383499 Free PMC article.

10

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.

Lapteva N, Durett AG, Sun J, Rollins LA, Huye LL, Fang J, Dandekar V, Mei Z, Jackson K, Vera J, Ando J, Ngo MC, Coustan-Smith E, Campana D, Szmania S, Garg T, Moreno-Bost A, Vanrhee F, Gee AP, Rooney CM. Lapteva N, et al. Cytotherapy. 2012 Oct;14(9):1131-43. doi: 10.3109/14653249.2012.700767. Epub 2012 Aug 17. Cytotherapy. 2012. PMID: 22900959 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters